NDC 68071-2928-01 - Nitrofurantoin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-2928
- Requested NDC
- 68071-2928-01
- Package NDCs from labels
- 68071-2928-4, 68071-2928-6, 68071-2928-2, 68071-2928-1, 68071-2928-01
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2026-09-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nitrofurantoin Capsules USP (Monohydrate/Macrocrystals) | NuCare Pharmaceuticals,Inc. | 2026-09-22 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-2928-4 | Nitrofurantoin | 14 in 1 BOTTLE | CAPSULE | 14 | 3 | |
| 68071-2928-6 | Nitrofurantoin | 6 in 1 BOTTLE | CAPSULE | 6 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-2928 | NITROFURANTOIN CAPSULE [NUCARE PHARMACEUTICALS,INC.] | 3 | Current NDC, 2 package rows | 20231021_f40af3e1-e54c-3a35-e053-2a95a90a6cb2.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NITROFURANTOIN MONOHYDRATE MACROCRYSTALLINE | NITROFURANTOIN MONOHYDRATE | Direct_Rx | 8d2e456a-ffb2-3f1e-e053-2995a90a22df | 2025-07-09 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| NITROFURANTOIN (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | Jubilant Cadista Pharmaceuticals Inc. | 1f7a9414-5592-f2ca-e063-6394a90a75f4 | 2025-06-30 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| Nitrofurantoin | NITROFURANTOIN | Micro Labs Limited | d96098d0-3c2b-4e53-a3f0-3ebba81c4133 | 2025-05-14 | Warnings, Adverse reactions | 1648755 927AH8112L |
| Nitrofurantoin (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | Bryant Ranch Prepack | 63a4b367-bf4b-4b5f-b3e9-394ba307886d | 2025-04-10 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| Nitrofurantoin | NITROFURANTOIN | Redpharm Drug, Inc. | f4c2c01d-bef7-3e5d-e053-2995a90ae0d8 | 2025-01-23 | Warnings, Adverse reactions | ANDA208516 1648755 E1QI2CQQ1I 927AH8112L |
| NITROFURANTOIN | NITROFURANTOIN | Directrx | d4385368-46d6-8397-e053-2a95a90a8d68 | 2025-01-17 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| NITROFURANTOIN (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | NCS HealthCare of KY, LLC dba Vangard Labs | d1825b58-2c00-475d-8d9b-cc07c66383f5 | 2025-01-15 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| NITROFURANTOIN (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | Asclemed USA, Inc. | ee3f300a-d6d3-49c4-bd60-425f04d30b88 | 2025-01-09 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| Nitrofurantoin (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | NuCare Pharmaceuticals,Inc. | 68a651f9-1aef-792e-e053-2991aa0a3cbb | 2024-12-30 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| NITROFURANTOIN | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | Aurobindo Pharma Limited | 788f1fe3-d8a1-42cc-9280-07f842da34ea | 2024-12-18 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| NITROFURANTOIN | NITROFURANTOIN | Biocon Pharma Inc | 68c718a7-2e8f-288c-37d2-053372ee61b9 | 2024-11-14 | Warnings, Adverse reactions | 927AH8112L |
| Nitrofurantoin (monohydrate/macrocrystals) | NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS | Amneal Pharmaceuticals LLC | 55c75f27-b5fc-4f19-8607-08f8ec0c69ec | 2024-10-30 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| Nitrofurantoin | NITROFURANTOIN | Amneal Pharmaceuticals LLC | 11dcea9c-0c62-4153-976b-bd1f8ef1f6d9 | 2024-10-30 | Warnings, Adverse reactions | 927AH8112L |
| nitrofurantoin (macrocrystals) | NITROFURANTOIN (MACROCRYSTALS) | A-S Medication Solutions | bc90b22e-e48a-4a22-b328-ca5bb2561864 | 2024-10-15 | Warnings, Adverse reactions | 927AH8112L |
| Nitrofurantoin | NITROFURANTOIN | ANI Pharmaceuticals, Inc. | 3b377aff-2d4b-43ea-84c9-8e72c1421b7b | 2024-10-08 | Warnings, Adverse reactions | 927AH8112L |
| nitrofurantoin (macrocrystals) | NITROFURANTOIN (MACROCRYSTALS) | Aurobindo Pharma Limited | b2fc8354-b413-4c9d-88ec-ccc43d059d51 | 2024-10-05 | Warnings, Adverse reactions | 927AH8112L |
| Nitrofurantoin | NITROFURANTOIN | Bryant Ranch Prepack | 56e07ad3-7224-4aaf-9a68-0d48d4abfec8 | 2024-08-28 | Warnings, Adverse reactions | ANDA208516 1648755 E1QI2CQQ1I 927AH8112L |
| NITROFURANTOIN (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | Jubilant Cadista Pharmaceuticals Inc. | 266824c7-7e9f-4c5f-b642-3bb7bf1c4fe6 | 2024-08-27 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
| nitrofurantoin macrocrystals | NITROFURANTOIN MACROCRYSTALS | Proficient Rx LP | ef7053f3-3081-49c4-9c78-d40a01177fd9 | 2024-08-19 | Warnings, Adverse reactions | 927AH8112L |
| Nitrofurantoin (monohydrate/macrocrystals) | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | Proficient Rx LP | f49f586a-79f0-4731-97f9-9aeb0839ece5 | 2024-08-19 | Warnings, Adverse reactions | 1648755 E1QI2CQQ1I 927AH8112L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.